Give people hope; restore federal funding for medical research
Budget cuts over the past year have led to an estimated 1,000 fewer research labs being funded
September 24, 2014 12:00 AM
By Dr. Arthur S. Levine
The failure of Congress to approve funding for the National Institutes of Health for the fiscal year that begins Oct. 1 is yet another blow to patients and families whose hopes for alleviating their burden of disease and disability are intertwined with groundbreaking biomedical research.
On behalf of the physicians, scientists and health professionals at the University of Pittsburgh, who are committed to improving the health of our community, I call on Congress to pass an NIH funding bill that restores the indiscriminate budget cuts enacted two years ago as part of budget sequestration.
For nearly 70 years, the nation’s research investment through NIH has improved our understanding of the causes of disease, increased life expectancy and enhanced the health and well-being of Americans everywhere. Every day, physicians and scientists at the nation’s medical schools, teaching hospitals and universities, including Pitt, see the promise that biomedical research brings.
Over time, NIH-funded research has led to a decline of more than 60 percent in deaths from heart disease and stroke. NIH-supported advances have led to tests to predict breast cancer recurrence, the discovery of genetic markers for complex illnesses, improved asthma treatments and the near-elimination of HIV transmission between mother and child. These and other medical breakthroughs have saved tens of thousands of lives, while new prevention methods and treatments continue to save countless more.
All of us — yes, even doctors and legislators — are going to be patients one day. We all get to sit on the exam table in that awkward paper gown. I urge our representatives to consider what it is like to face uncertainty in that moment.
For example, should you go forward with surgery if you don’t know whether your particular cancer is going to grow and spread or simply remain dormant? If you learn that you show signs of Alzheimer’s disease, are there steps you can take to preserve the function you have so that you can live independently for as long as possible? The most unsettling response to questions like these is, “We don’t know enough to answer that right now.”
With support from the federal government, Pitt researchers are helping to provide better answers. As noted in the pages of this newspaper just in the past two months, our faculty members are developing new gene tests to identify which prostate cancers require aggressive treatment; exploring how brain health is influenced by lifestyle choices, depression and other factors to possibly prevent dementia and cognitive decline; and creating new insights into pancreatitis treatment by identifying unanticipated relationships to cystic fibrosis. These are just a few examples of the hope that NIH-funded studies give the nation’s patients and families.
Physicians and scientists at U.S. medical schools and teaching hospitals conduct more than half of all external research funded by NIH. In fiscal year 2013, Pennsylvania ranked fourth nationally with more than 3,500 NIH grants and fifth nationally with more than 52,500 NIH-supported jobs. Pitt ranks sixth nationally in NIH dollars awarded, with more than $430 million in total funding, leaving Pitt and the state disproportionately vulnerable to declining NIH support.
Despite the many important life-saving discoveries resulting from NIH-supported research, recent budget cuts slashed NIH’s budget by $1.7 billion over the past year, which led directly to an estimated 1,000 fewer research labs being funded than just the year before.
In 2012, NIH-funded research supported more than 400,000 jobs across the country. The nation’s investment in NIH also is the foundation for long-term U.S. global competitiveness in industries such as biotechnology, medical device manufacturing and pharmaceutical development.
The United States is the world’s leader in medical innovation. Nobody doubted that fact when the NIH appropriation doubled between 1998 and 2003. Now, China, India and other countries are challenging our dominance by vastly increasing public funding for medical research. By failing to sustain our commitment to medical research, we risk losing our leadership position at the most critical scientific frontier of the 21st century.
We at the University of Pittsburgh, along with other U.S. medical schools and teaching hospitals, urge Congress to restore the NIH budget and reaffirm medical research as a top national priority. Americans deserve cures, not cuts.
Arthur S. Levine, M.D., is senior vice chancellor for the health sciences and the John and Gertrude Petersen Dean of the School of Medicine at the University of Pittsburgh.
To report inappropriate comments, abuse and/or repeat offenders, please send an email to
firstname.lastname@example.org and include a link to the article and a copy of the comment. Your report will be reviewed in a timely manner.